Roivant Sciences Ltd (ROIV)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 299 |
| % of all portfolios: | 0.037% |
| Hold Price * : | $27.70 |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q1 2026 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 1,626,940 | 0.52 | |
| ≡ | David Einhorn - Greenlight Capital | Add 4.03% | 83,360 | 0.07 | |
| ≡ | Viking Global Investors | Add 3.25% | 209,257 | 0.02 | |
| Q4 2025 | |||||
| ≡ | Polen Capital Management | Buy | 9,662 | 0.00 | |
| Q1 2025 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 3.23% | 170,100 | 0.09 | |
| Q3 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 10.33% | 497,080 | 0.24 | |
| Q2 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Add 14.81% | 620,470 | 0.32 | |
| Q1 2024 | |||||
| ≡ | David Einhorn - Greenlight Capital | Buy | 4,190,490 | 2.02 | |
| Q4 2021 | |||||
| ≡ | Viking Global Investors | Buy | 88,238,700 | 2.58 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.